Login to Your Account

Financings Roundup

Wednesday, December 12, 2012

• Derma Sciences Inc., of Princeton, N.J., said it closed its public offering of about 3.5 million shares priced at $10.34 apiece, including the exercise of the underwriters' option to purchase 459,300 shares to cover overallotments. Net proceeds totaled about $33.8 million and will be used to support continued development of DSC127 for the treatment of diabetic foot ulcers, as well as for general corporate purposes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription